Heartbeam Inc (BEAT)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $25.04M
Last updated: Nov 17, 2026 at 11:05 AM ET
Heartbeam Inc (BEAT) Stock Forecast
Analysts expect Heartbeam (BEAT) to earn -$0.38 per share in the fiscal year ending Dec 31, 2026, on revenue of $288330. Of 3 analysts, 2 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 67% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 33.3% |
| Buy | 1 | 33.3% |
| Hold | 1 | 33.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 1197.1%.
- Fiscal year ending Dec 31, 2026
- -$0.38
- EPS consensus, revenue $288330
- Fiscal year ending Dec 31, 2027
- -$0.29
- EPS consensus, revenue $3.74M
- Next report
- Mar 10, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.38 | -$0.41 to -$0.37 | 3 | $288330 | $40000 to $700000 | 3 |
| Dec 31, 2027 | -$0.29 | -$0.34 to -$0.24 | 3 | $3.74M | $120000 to $6.70M | 3 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.09 | -$0.10 to -$0.08 | 5 | $204000 | N/A | 5 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.37.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.38 | -$0.38 | -$0.38 | -$0.40 | -$0.37 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.29 | -$0.29 | -$0.29 | -$0.31 | -$0.30 | N/A |
Frequently Asked Questions About BEAT
What is the BEAT stock forecast?
Consensus analyst estimates put Heartbeam's EPS at -$0.38 for the fiscal year ending Dec 31, 2026, on revenue of $288330. The consensus rating from 3 analysts is Buy.
How do analysts rate BEAT stock?
Of 3 analysts covering Heartbeam, 1 rates it Strong Buy, 1 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from BEAT next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.38, with estimates from -$0.41 to -$0.37 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.29, with estimates from -$0.34 to -$0.24 from 3 analysts.
What revenue do analysts expect from Heartbeam next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $288330, with estimates from $40000 to $700000. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.74M, with estimates from $120000 to $6.70M.
How many analysts cover BEAT?
3 analysts rate Heartbeam stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
BEAT pages: Overview, Earnings, Forecast, Financials, Competitors